ACCOUNT

Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

PGe
NEWSLETTERS
PG STORE
ARCHIVES

CLASSIFIEDS

OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS

CONTACT US
ADVERTISING
CAREER OPPORTUNITIES

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Clearmind Medicine Inc. - Common Shares (NQ:CMND)

0.9501 -0.0199 (-2.05%)

Streaming Delayed Price Updated: 10:39 AM EDT, Sep 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Clearmind Medicine Inc. - Common Shares

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Aegis Capital Corp. Acted as Sole Bookrunner on a $2.4 Million Registered Direct and Private Placement for Clearmind Medicine Inc. (NASDAQ: CMND)

January 16, 2024

Via ACCESSWIRE

Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More ↗

January 15, 2024

Welcome to Benzinga's weekly psychedelics headlines roundup. This is our pick of must-read news items from the second week of January 2024.

Via Benzinga

Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More ↗

January 12, 2024

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD

Via Benzinga

Crude Oil Moves Higher; Clearmind Medicine Shares Plummet ↗

January 11, 2024

U.S. stocks traded slightly lower toward the end of trading, with the Dow Jones index falling around 20 points on Thursday. The Dow traded down 0.05% to 37,675 while the NASDAQ fell 0.05% to 14,962.80....

Via Benzinga

Topics Stocks

Clearmind Medicine Stock Is Soaring: What's Going On? ↗

January 10, 2024

Via Benzinga

Why TechTarget Shares Are Trading Higher By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 11, 2024

Shares of TechTarget, Inc. (NASDAQ: TTGT) rose sharply during Thursday’s session after the company announced a strategic combination with Informa Tech's digital businesses. TechTarget shares surged...

Via Benzinga

Dow Dips Over 200 Points; First Financial Northwest Shares Spike Higher ↗

January 11, 2024

U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 200 points on Thursday. The Dow traded down 0.56% to 37,483.91 while the NASDAQ fell 0.86% to 14,840.28. The S&P...

Via Benzinga

Topics Stocks

Why Clearmind Medicine (CMND) Shares Are Nosediving ↗

January 11, 2024

Clearmind Medicine Inc (NASDAQ: CMND) shares are trading lower by 45% to $1.61 Thursday morning after the company finalized agreements with institutional investors for a

Via Benzinga

US Stocks Higher; Inflation Rate Increases To 3.4% In December ↗

January 11, 2024

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Thursday. Following the market opening Thursday, the Dow traded up 0.07% to 37,723.53 while the NASDAQ rose...

Via Benzinga

Topics Economy Stocks

CRM Stock Alert: Baird Boosts Salesforce With New Upgrade ↗

January 11, 2024

Salesforce stock is gaining on Thursday after shares of CRM got an upgrade and increased price target from Baird analysts.

Via InvestorPlace

Clearmind Medicine Inc. Announces Pricing of $2.4 Million Registered Direct and Private Placement

January 11, 2024

From Clearmind Medicine Inc.

Via GlobeNewswire

Goldman Sachs Is Cooling Off on LYFT Stock ↗

January 11, 2024

Lyft stock is on the move Thursday after the ridesharing company's shares were hit with a downgrade from Goldman Sachs.

Via InvestorPlace

Why Is Clearmind Medicine (CMND) Stock Down 24% Today? ↗

January 11, 2024

Clearmind Medicine stock is falling on Thursday after shares of CMND underwent a major rally yesterday on a meeting with regulators.

Via InvestorPlace

Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket ↗

January 11, 2024

Shares of Richardson Electronics, Ltd. (NASDAQ: RELL) fell sharply in today’s pre-market trading after the company posted weaker-than-expected results for its second quarter.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 11, 2024

It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning!

Via InvestorPlace

Crude Oil Falls 1%; Amarin Shares Spike Higher ↗

January 10, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Wednesday. The Dow traded up 0.29% to 37,633.43 while the NASDAQ rose 0.72% to 14,965.31. The...

Via Benzinga

Topics Stocks

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 10, 2024

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.

Via Benzinga

Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week ↗

January 10, 2024

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 50 points on Wednesday. The Dow traded up 0.17% to 37,588.15 while the NASDAQ rose 0.34% to 14,908.42. The S&P...

Via Benzinga

Topics Stocks

Trend Micro Layoffs 2024: What to Know About the Latest TMICY Job Cuts ↗

January 10, 2024

Trend Micro layoffs have the Japanese cybersecurity company cutting 2% of its global workforce as part of its business transformation.

Via InvestorPlace

Topics Workforce

Dow Surges 100 Points; PriceSmart Earnings Top Views ↗

January 10, 2024

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.27% to 37,627.83 while the NASDAQ rose...

Via Benzinga

Topics Stocks

Why Is Clearmind (CMND) Stock Up 40% Today? ↗

January 10, 2024

The jump in Clearmind sent its market cap to $6 million. The study of psychedelic compounds to treat mental illness is growing.

Via InvestorPlace

Clearmind Medicine Completed Type A Meeting with the FDA

January 10, 2024

From Clearmind Medicine Inc.

Via GlobeNewswire

Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More ↗

January 07, 2024

Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury

Via Benzinga

SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments

January 04, 2024

From SciSparc Ltd

Via GlobeNewswire

Clearmind Medicine and SciSparc Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic- Based Treatments

January 04, 2024

From Clearmind Medicine Inc.

Via GlobeNewswire

Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More ↗

December 27, 2023

President Biden Approves Psychedelics Clinical Trials For Active Military Members President Biden signed into law the 2024 National Defense Authorization Act (NDAA), large-scale legislation that also...

Via Benzinga

Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More ↗

December 18, 2023

Biden To Decide On Psychedelic Therapy Bill

Via Benzinga

Clearmind Medicine Announces It Is In Compliance with All Applicable Nasdaq Listing Standards

December 14, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 12, 2023

Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session following weak quarterly results.

Via Benzinga

Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket ↗

December 12, 2023

Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.